Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer
NCT01442974
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
Gemcitabine plus nab-paclitaxel
Sponsor
Grupo Hospital de Madrid